Blood clots are healthy and lifesaving when they discontinue bleeding. However, they can also form abnormally, causing stroke, a heart attack, or other severe medical problems. It is normal in cases of injury, but pathologic in particular cases of thrombosis. It forms when blood fails to circulate appropriately. It is an important mechanism to help the body repair injured blood vessels. Blood must flow uninterruptedly and smoothly for an entire lifetime, but quickly form a clot when bleeding occurs. Blood accomplishes this through complex interactions between substances in blood and the blood vessel walls. Causes: •The process of it is triggered whenever flowing blood is exhibited to certain substances. There are many such substances, which are known as thrombogenic because they boost the formation of thrombus (another name for a clot). •Many thrombogenic substances are situated in the skin or in blood vessel walls. Safely separated from flowing blood, their contact with blood normally means the blood vessel wall is ruptured and is bleeding. •Most strokes and heart attacks result from the unexpected formation of a blood clot on a waxy cholesterol plaque inside an artery in the brain or heart. When the plaque ruptures abruptly, thrombogenic substances inside the plaque are exposed to blood, causing the blood clotting process. •Blood clots may also constitute when blood fails to flow properly. •Immobilization which is longer than usual can diminish blood flow in the legs, raising the risk for blood clots in leg veins. Treatment: Medications and medical conditions can change the process of blood clot formation, making them more or less likely. The treatment diminishes the risk of heart attack, stroke, and pulmonary embolism. Some examples are: •Aspirin, Effient, Brilinta, and clopidogrel (Plavix): These are drugs that intervene with platelet function, making blood clots less likely. •Warfarin (Coumadin): An oral drug that minimizes production of clotting factors, diminishing blood clotting. •Heparin: An injectable or intravenous drug that intervenes with thrombin, precluding blood clot formation. •Tissue plasminogen activator (TPA): A clot-dissolving drug that makes plasmin, and is occasionally given as a treatment for stroke or heart attack. •Hypercoagulable state: An inappropriate balance between clotting factors and clot-reducing substances that outcome in increased likelihood of abnormal blood clots. •Hemophilia. A genetic deficiency of certain functioning clotting factors results in poor blood clotting and excessive bleeding. •Von Willebrand factor deficiency. A relatively general condition resulting in slow blood clot formation, which is normally mild. John Anderson is a Health Content Writer For Kamagra.biz, adviser by profession.He is associate with many Pharmacies for whom he writes articles based on generic Medicines like Cheap Kamagra Online and Best Price Kamagra Jelly and general health related issues.
Related Articles -
blood clots, intravenous, clopidogrel, cholesterol, kamagra biz,
|